Impact of an 8-week Linoleic Acid Intake in Soy Oil on Lp-PLA2 Activity in Healthy Adults
- Conditions
- Healthy Subjects
- Interventions
- Dietary Supplement: Low LADietary Supplement: High LA
- Registration Number
- NCT02753907
- Lead Sponsor
- Yonsei University
- Brief Summary
Self-reported healthy participants (n=150) aged 30-65 years with 18.5 kg/m\^2 ≤ BMI \< 30 kg/m\^2 were randomly assigned into three groups: a low linoleic acid (LA, 18:2n-6) group (n=50) replaced 10 mL soy oil with one apple; a medium LA group (control group, n=50) maintained usual food intake; a high LA group (n=50) reduced 1/3 cup of cooked refined rice and consumed 9.9g of soy oil capsules daily as a supplement. Plasma fatty acids and lipoprotein-associated phospholipase A2 (Lp-PLA2) activity were measured at baseline and 8 week alongside other cardiovascular disease risk factors.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
- Age 30 to 65 years at beginning of study
- Subjects with BMI 18.5 to 30 kg/m^2
- Use of any medication or supplements that alter lipid metabolism.
- Presence of dyslipidemia, diabetes mellitus, hypertension, liver disease, renal disease, chronic disease of the gastrointestinal tract, cerebrovascular disease, pancreatitis or cancer.
- Women who pregnant or lactating.
- Drug or alcohol abuse.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Low LA (linoleic acid) Low LA Individuals who replaced 10 mL soy oil with one apple High LA High LA Individuals who reduced 1/3 cup of cooked refined rice and consumed 9.9 g of soy oil as a supplement
- Primary Outcome Measures
Name Time Method Change in Lp-PLA2 activity (nmol/mL/min) At baseline and end of each 8-week diet period
- Secondary Outcome Measures
Name Time Method Change in LDL cholesterol (mg/dL) At baseline and end of each 8-week diet period Lipids and lipoproteins, such as total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, Apo A-I, Apo B
Change in HDL cholesterol (mg/dL) At baseline and end of each 8-week diet period Change in triglyceride (mg/dL) At baseline and end of each 8-week diet period Change in total cholesterol (mg/dL) At baseline and end of each 8-week diet period
Trial Locations
- Locations (1)
Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University.
🇰🇷Seoul, Korea, Republic of